TERT and head and neck squamous cell carcinoma: Next, we investigated whether combinations of these two variables can refine the prediction of a patient's prognosis: the combination of high TERT expression (TERThigh) with high B cell infiltration (Bhigh) identified a subset of HNSCC patients with favorable outcome (n = 49; Bhigh/TERThigh group), compared with patients with low TERT expression and high B cells (n = 41, Bhigh/TERTlow group) (Fig. 2B).